Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis
- PMID: 19667024
- DOI: 10.1177/1352458509106213
Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis
Abstract
Background: Studies in multiple sclerosis (MS) report conflicting conclusions regarding fatigue and cognition, which may partly be due to the use of small sample sizes and frequent reliance on a cross-sectional approach.
Objective: The ability to distinguish between these two disabling symptoms is necessary in order to properly assess and treat MS patients.
Methods: In a retrospective analysis, we assessed the correlation between fatigue and neuropsychological (NP) testing using a cross-sectional (n = 465) and longitudinal approach (n = 69). Cognition was measured using a comprehensive battery called the Minimal Assessment of Cognitive Function in MS (MACFIMS), and fatigue was measured with the Fatigue Severity Scale (FSS). FSS scores were categorized as normal (<or=4.0), borderline fatigue (4 < FSS < 5.0), and fatigued (>or=5.0). Repeat assessments (n = 69) were categorized as improved or worsened by a change in FSS of either 0.5 or 1.0.
Results: MS patients had significantly higher FSS scores than normal controls (P < 0.001). No correlation was found between FSS and NP scores in either cross-sectional or longitudinal analyses. Fatigue was moderately correlated with depression, assessed using the Beck Depression Inventory Fast Screen (BDIFS) (r = 0.44, P < 0.001). Longitudinally, there was a medium correlation between change in FSS and BDIFS (r = 0.34, P = 0.001), but no significant differences on NP scores using either definition of change.
Conclusion: We conclude that self-reported fatigue, while correlated with self-reported depression, is not significantly related to cognitive capacity in MS.
Similar articles
-
Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.J Neurol Sci. 2006 Jul 15;246(1-2):117-22. doi: 10.1016/j.jns.2006.02.018. Epub 2006 May 5. J Neurol Sci. 2006. PMID: 16678208
-
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.Mult Scler. 2010 Feb;16(2):228-37. doi: 10.1177/1352458509354552. Epub 2009 Dec 22. Mult Scler. 2010. PMID: 20028710
-
Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire.Mult Scler. 2008 Aug;14(7):940-6. doi: 10.1177/1352458508090923. Epub 2008 Jun 23. Mult Scler. 2008. PMID: 18573822
-
Minimal neuropsychological assessment of MS patients: a consensus approach.Clin Neuropsychol. 2002 Aug;16(3):381-97. doi: 10.1076/clin.16.3.381.13859. Clin Neuropsychol. 2002. PMID: 12607150 Review.
-
[Depression in multiple sclerosis].Rev Neurol (Paris). 2009 Mar;165 Suppl 4:S156-62. doi: 10.1016/S0035-3787(09)72128-9. Rev Neurol (Paris). 2009. PMID: 19361681 Review. French.
Cited by
-
Cortical thinning in the anterior cingulate cortex predicts multiple sclerosis patients' fluency performance in a lateralised manner.Neuroimage Clin. 2015 Nov 14;10:89-95. doi: 10.1016/j.nicl.2015.11.008. eCollection 2016. Neuroimage Clin. 2015. PMID: 26759784 Free PMC article.
-
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.CNS Drugs. 2016 Mar;30(3):209-25. doi: 10.1007/s40263-016-0319-6. CNS Drugs. 2016. PMID: 26884145 Review.
-
Cognitive Fatigue in Multiple Sclerosis: An Objective Approach to Diagnosis and Treatment by Transcranial Electrical Stimulation.Brain Sci. 2019 May 2;9(5):100. doi: 10.3390/brainsci9050100. Brain Sci. 2019. PMID: 31052593 Free PMC article. Review.
-
Dynamics of saccade parameters in multiple sclerosis patients with fatigue.J Neurol. 2012 Dec;259(12):2656-63. doi: 10.1007/s00415-012-6565-8. Epub 2012 Jun 19. J Neurol. 2012. PMID: 22711158
-
Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation.Curr Treat Options Neurol. 2018 Oct 22;20(12):53. doi: 10.1007/s11940-018-0538-x. Curr Treat Options Neurol. 2018. PMID: 30345468 Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous